Epland, Kristin
Suez, Daniel
Paris, Kenneth
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
Article History
Received: 22 February 2022
Accepted: 7 September 2022
First Online: 30 September 2022
Declarations
:
: Not applicable.
: Not applicable.
: Kristin Epland is a paid consultant for Takeda Pharmaceuticals and is a member of their speaker’s bureau; she also sits on the Nurse Advisory Committee of the Immune Deficiency Foundation. Daniel Suez has nothing to declare. Kenneth Paris has been a participant in advisory boards/consulting, a speaker on use of IG and shared decision making, and an investigator on clinical trials and others for Shire/Takeda; a speaker for the Immune Deficiency Foundation; and an advocacy committee member for the Clinical Immunology Society.